LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosis
about
The pathogenesis of chronic lymphocytic leukemiaCharacterization of a new chronic lymphocytic leukemia cell line for mechanistic in vitro and in vivo studies relevant to diseaseHigh throughput chemical library screening identifies a novel p110-δ inhibitor that potentiates the anti-myeloma effect of bortezomibGenome-wide association study identifies multiple risk loci for chronic lymphocytic leukemiaDifferentiation of chronic lymphocytic leukemia B cells into immunoglobulin secreting cells decreases LEF-1 expression.Network Biomarkers Constructed from Gene Expression and Protein-Protein Interaction Data for Accurate Prediction of LeukemiaMetadherin contribute to BCR signaling in chronic lymphocytic leukemiaGenome-wide transcriptional analysis of T cell activation reveals differential gene expression associated with psoriasis.Somatic mutation as a mechanism of Wnt/β-catenin pathway activation in CLL.SF3B1 and other novel cancer genes in chronic lymphocytic leukemiaPKC-β as a therapeutic target in CLL: PKC inhibitor AEB071 demonstrates preclinical activity in CLL.Concurrent epigenetic silencing of wnt/β-catenin pathway inhibitor genes in B cell chronic lymphocytic leukaemia.Molecular characterization of chronic lymphocytic leukemia patients with a high number of losses in 13q14.Role of microRNA profile modifications in hepatitis C virus-related mixed cryoglobulinemiaExpression and role of RIP140/NRIP1 in chronic lymphocytic leukemia.Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells.Characterization of LEF1 High Expression and Novel Mutations in Adult Acute Lymphoblastic LeukemiaMethylprednisolone suppresses the Wnt signaling pathway in chronic lymphocytic leukemia cell line MEC-1 regulated by LEF-1 expressionIdentification of LMO2 transcriptome and interactome in diffuse large B-cell lymphoma.Genome-wide DNA methylation analysis reveals novel epigenetic changes in chronic lymphocytic leukemia.Understanding multicellular function and disease with human tissue-specific networks.Chronic lymphocytic leukemia: molecular heterogeneity revealed by high-throughput genomicsHigh LEF1 expression predicts adverse prognosis in chronic lymphocytic leukemia and may be targeted by ethacrynic acidNon-myogenic tumors display altered expression of dystrophin (DMD) and a high frequency of genetic alterations.Lymphoid enhancer binding factor-1 (LEF1) expression as a prognostic factor in adult acute promyelocytic leukemia.B-lineage transcription factors and cooperating gene lesions required for leukemia development.Uncovering the DNA methylome in chronic lymphocytic leukemia.Wnt signaling in leukemias and myeloma: T-cell factors are in control.Chronic lymphocytic leukaemia: could immunological tolerance mechanisms be the origin of lymphoid neoplasms?Factors involved in CLL pathogenesis and cell survival are disrupted by differentiation of CLL B-cells into antibody-secreting cells.C/EBPa-mediated activation of microRNAs 34a and 223 inhibits Lef1 expression to achieve efficient reprogramming into macrophages.Targeting the canonical Wnt/β-catenin pathway in hematological malignancies.GSK3β inactivation induces apoptosis of leukemia cells by repressing the function of c-Myb.Indolent lymphomas in the pediatric population: follicular lymphoma, IRF4/MUM1+ lymphoma, nodal marginal zone lymphoma and chronic lymphocytic leukemia.Blockage of Wnt/β-Catenin Signaling by Nanoparticles Reduces Survival and Proliferation of CLL Cells In Vitro-Preliminary Study.Dishevelled proteins are significantly upregulated in chronic lymphocytic leukaemia.Microenvironmental interactions between endothelial and lymphoma cells: a role for the canonical WNT pathway in Hodgkin lymphoma.A seven-gene expression panel distinguishing clonal expansions of pre-leukemic and chronic lymphocytic leukemia B cells from normal B lymphocytes.Metadherin contributes to the pathogenesis of chronic lymphocytic leukemia partially through Wnt/β-catenin pathway.Wnt signalling pathways in chronic lymphocytic leukaemia and B-cell lymphomas.
P2860
Q27025715-98424345-476F-4CE9-BAD0-F95D93201135Q27304652-2B4E6DF4-602D-4E1C-9D58-87F1E62333A0Q28818948-E2B141B7-03B0-4A2A-AF2D-C52541BF0EF8Q28943339-2624DEBB-4F9F-4554-AFCA-337B6B8EE4D3Q31038111-116E91E3-BF6E-47F7-97C6-8CCFD64792C8Q31167575-D9BFA701-CA02-4E8D-9723-930AF61C0A71Q33583000-B2A710D6-25F5-4BEB-A9FE-43931699244DQ33715534-2EDD0654-29D6-485F-B9B8-02A162A82628Q34047852-A6C34F37-4722-46A8-87C2-B6ED359C0323Q34093678-87ECAA58-4C82-43A1-BFB9-BBFA33DC49C5Q34106863-E2270532-CF76-4133-AFC2-6D8925E5F92BQ34294336-0570928B-FD20-4394-86EC-3D34D2F2891FQ34477348-76F8862E-3D9A-47E7-8E77-6CA434C92585Q34708468-AE411F7D-3E12-47E1-B0A2-1B6C913E6145Q35162589-EC3B6051-8891-49D6-97DE-A544598957A8Q35164584-D286448B-19A9-4E28-99FB-830CD8B6A267Q35571669-7C198872-3797-45FA-B840-7BE3ECDADFBCQ36014206-C0E948B6-5000-430C-9D01-7937B075FE39Q36015211-92C7AA77-890F-4C59-A024-A1D30B51558BQ36100977-72C9A934-C353-468D-A3F0-BCF437095819Q36790036-04A0525C-C674-4309-8A6F-F70FE479958FQ36998431-F656DC20-3C85-4A5C-BE04-8B3487C8E086Q37225362-410A089C-D369-4D44-AC63-15A32697D74EQ37702112-AF4B72BC-A8B1-48EC-B09A-309B0EC35BB2Q37718455-A06C4D31-5307-4F91-84D7-527D9CB345A5Q38050656-180F7822-1668-416B-B0B8-3BF0B50B68DFQ38074267-75F663D6-5AD7-43D7-A2BA-C9763E83C35EQ38155205-ABBEA9DF-28C9-4BBE-AA49-CB26EC44777FQ38197232-5D82629D-7E75-4F6D-AF84-9DB2B4DBB355Q38298483-A279E4C3-B99B-42EC-AEFB-98E7E68088FEQ38329027-0E1EAF22-AAE4-485A-B2E8-4F08BC872448Q38383469-B48EA8B2-91E9-4197-843D-CB2D8B9EA1F4Q38394964-AF8C1970-E63C-450A-B078-3180E217F18FQ38594789-24F85042-94A2-4170-8A30-41FA4A904A1AQ38649711-93C5B026-2B26-4F10-AF58-E9286B943B70Q38737124-AAD591D9-1A31-48CA-A148-7755B68C3413Q38751343-B76F8715-1E75-4216-894B-380B9B0B6305Q38839768-644E02EA-E2EE-4B71-92E3-BA1D6078F127Q38921580-4300A354-AFE1-4E69-9D2C-2FB768F395E5Q39432317-5FC4DCA2-38D0-4F38-B25A-ED34B0D007E8
P2860
LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosis
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
LEF-1 is a prosurvival factor ...... onoclonal B-cell lymphocytosis
@ast
LEF-1 is a prosurvival factor ...... onoclonal B-cell lymphocytosis
@en
LEF-1 is a prosurvival factor ...... onoclonal B-cell lymphocytosis
@nl
type
label
LEF-1 is a prosurvival factor ...... onoclonal B-cell lymphocytosis
@ast
LEF-1 is a prosurvival factor ...... onoclonal B-cell lymphocytosis
@en
LEF-1 is a prosurvival factor ...... onoclonal B-cell lymphocytosis
@nl
prefLabel
LEF-1 is a prosurvival factor ...... onoclonal B-cell lymphocytosis
@ast
LEF-1 is a prosurvival factor ...... onoclonal B-cell lymphocytosis
@en
LEF-1 is a prosurvival factor ...... onoclonal B-cell lymphocytosis
@nl
P2093
P2860
P1433
P1476
LEF-1 is a prosurvival factor ...... onoclonal B-cell lymphocytosis
@en
P2093
Albert Gutierrez
Diane F Jelinek
Jeanette Eckel-Passow
Neil E Kay
Paul M Huddleston
Renee C Tschumper
Susan L Slager
Tait D Shanafelt
Xiaosheng Wu
P2860
P304
P356
10.1182/BLOOD-2010-02-269878
P407
P577
2010-07-01T00:00:00Z